1. Home
  2. RGEN vs FLR Comparison

RGEN vs FLR Comparison

Compare RGEN & FLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • FLR
  • Stock Information
  • Founded
  • RGEN 1981
  • FLR 1912
  • Country
  • RGEN United States
  • FLR United States
  • Employees
  • RGEN N/A
  • FLR N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • FLR Military/Government/Technical
  • Sector
  • RGEN Health Care
  • FLR Industrials
  • Exchange
  • RGEN Nasdaq
  • FLR Nasdaq
  • Market Cap
  • RGEN 6.5B
  • FLR 6.7B
  • IPO Year
  • RGEN N/A
  • FLR N/A
  • Fundamental
  • Price
  • RGEN $119.39
  • FLR $40.35
  • Analyst Decision
  • RGEN Buy
  • FLR Buy
  • Analyst Count
  • RGEN 10
  • FLR 7
  • Target Price
  • RGEN $163.78
  • FLR $50.57
  • AVG Volume (30 Days)
  • RGEN 718.1K
  • FLR 3.4M
  • Earning Date
  • RGEN 11-11-2025
  • FLR 11-07-2025
  • Dividend Yield
  • RGEN N/A
  • FLR N/A
  • EPS Growth
  • RGEN N/A
  • FLR 970.51
  • EPS
  • RGEN N/A
  • FLR 24.07
  • Revenue
  • RGEN $673,956,000.00
  • FLR $16,313,000,000.00
  • Revenue This Year
  • RGEN $16.79
  • FLR $3.29
  • Revenue Next Year
  • RGEN $13.68
  • FLR $4.33
  • P/E Ratio
  • RGEN N/A
  • FLR $1.67
  • Revenue Growth
  • RGEN 8.73
  • FLR 3.61
  • 52 Week Low
  • RGEN $102.97
  • FLR $29.20
  • 52 Week High
  • RGEN $182.52
  • FLR $60.10
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 49.56
  • FLR 38.62
  • Support Level
  • RGEN $112.73
  • FLR $40.24
  • Resistance Level
  • RGEN $122.71
  • FLR $41.81
  • Average True Range (ATR)
  • RGEN 4.85
  • FLR 1.31
  • MACD
  • RGEN -0.27
  • FLR 0.22
  • Stochastic Oscillator
  • RGEN 53.02
  • FLR 16.00

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About FLR Fluor Corporation

Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services.It serves a wide range of end markets, including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $16.3 billion in revenue in 2024.

Share on Social Networks: